Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fujimori, Nagano

Kazuhiro Fujimori, Nagano JP

Patent application numberDescriptionPublished
20090172924Tightenning Band - An upright portion of an inner band section is inserted into an elongated hole in an outer band section, and a tab-like stopper of the outer band section is inserted in a cutout hole on the base end side of the upright portion. As a result, a band member is temporarily held in a ring shape. When an inner and an outer pulling claw are pulled together, a fixing hole in the outer band section engages a fixing claw of the inner band section and the tab-like stopper engages a stopper receiving hole. This results in the band member being fixed with its diameter reduced.07-09-2009

Minoru Fujimori, Nagano JP

Patent application numberDescriptionPublished
200902800915-FLUOROURACIL-RESISTANT BACTERIA AND METHOD FOR PRODUCTION THEREOF - The present invention provides a method for producing a cytosine deaminase (CD)-expressing, 5-fluorouracil (5-FU)-resistant microorganism which can grow in anaerobic tumor tissues, can express CD, and has a resistance to 5-FU at a concentration that is at least effective for antitumor activity. More specifically, the method is a method (A) comprising performing subculture or acclimation culture of a CD-expressing microorganism which can grow in anaerobic tumor tissues, in the presence of 5-fluorocytosine (5-FC), or a method (B) comprising (1) performing subculture or acclimation culture of a microorganism which can grow in anaerobic tumor tissues and does not express CD, in the presence of 5-FU to produce a 5-FU-resistant microorganism and (2) transforming the 5-FU-resistant microorganism by introducing a CD gene. The present invention also provides the CD-expressing, 5-FU-resistant microorganism and a pharmaceutical composition comprising the microorganism.11-12-2009
20100129323Novel Shuttle Vector - The present invention provides a shuttle vector for a microorganism of the genus 05-27-2010

Noriyuki Fujimori, Nagano JP

Patent application numberDescriptionPublished
20090012357In-Vivo Image Acquiring System and Body-Insertable Apparatus - A capsule endoscope 01-08-2009
20090043155BODY-INSERTABLE APPARATUS, IN-VIVO INFORMATION ACQUIRING SYSTEM, AND BODY-INSERTABLE APPARATUS MANUFACTURING METHOD - An object of the present invention is to make it possible to closely examine a specific region by making most use of an advantage of a compound-eye capsule endoscope that picks up images of an interior of a body cavity forward and backward in a movement direction of a capsule casing. By disposing imaging devices (02-12-2009
20090118585BODY-INSERTABLE APPARATUS - In a capsule casing 05-07-2009
20100121150CAPSULE MEDICAL APPARATUS AND CURRENT-CARRYING CONTROL METHOD - An object of the present invention is to readily initiate an operation of a capsule medical apparatus which is inserted into a subject and executes a predetermined function. In a capsule endoscope 05-13-2010

Patent applications by Noriyuki Fujimori, Nagano JP

Shuichi Fujimori, Nagano JP

Patent application numberDescriptionPublished
20110256270RICE WRAPPER AND WRAPPED RICE - The present invention provides a rice wrapper, in which an outer film divided into two can be easily removed. One side part of the rice wrapper 10-20-2011

Takayuki Fujimori, Nagano JP

Patent application numberDescriptionPublished
20090120535METHOD OF BONDING STEEL MEMBERS, METHOD OF ENHANCING BONDING STRENGTH OF UNITED BODY FORMED OF STEEL MEMBERS, STEEL PRODUCT, AND DIE-CAST PRODUCT - The present invention provides a method of bonding steel members by bonding a plurality of steel members made of a Cr-containing steel material to each other. The method includes a united body forming step S05-14-2009

Yoshikazu Fujimori, Nagano JP

Patent application numberDescriptionPublished
20090286751PROGRESSION INHIBITOR FOR DISEASE ATTRIBUTED TO ABNORMAL ACCUMULATION OF LIVER FAT - The present invention provides pharmaceutical compositions useful as agents for the inhibition of progression of diseases associated with abnormal accumulation of liver lipids. In particular, the pharmaceutical compositions of the present invention which comprise as an active ingredient a sodium/glucose co-transporter 2 inhibitor are highly suitable as an agent for the inhibition of progression of not only common fatty liver but also non-alcoholic fatty liver disease (NAFL), non-alcoholic steatohepatitis (NASH), hypernutritive fatty liver, diabetic fatty liver, alcoholic fatty liver disease toxic fatty liver or the like.11-19-2009